Webcasts: Packaging

Extractables and Leachables: Trends and Future Directions Part II A roundtable discussion

Wednesday, May 25, 2022 at 11am EDT|8am PDT|5pm CEST|4pm BST In the last few years, the issuance of the ISO 10993-18:2020 medical device guidance and several high-profile publications and round robin studies have resulted in the FDA increasing scrutiny of E&L analyses for both drugs and devices. Join our panel of industry experts to discuss these changes and to learn the direction E&L studies may take in the future.

Testing of Packaging Systems for Large-Volume Parenteral Drugs: Extractables Study Design and Challenges

***Thursday, May 20, 2021, 2pm EDT | 1pm CDT | 11am PDT*** Flexible bag systems used for large-volume parenteral drug applications contain different materials that pose potential sources of contamination. In this webcast, learn about the sources of extractables and leachable, testing programs, regulatory requirements, and challenges specific to large-volume parenteral applications. *** On demand available after final airing until May 20, 2022.***

Using AI for CAPA and Root-Cause Investigations

*Thursday, May 6, 2021 at 2pm EDT | 1pm CDT | 11am PDT* Learn how artificial intelligence can be used to investigate corrective and preventive actions, pinpoint the root cause of the most common complaints, tell if training is effective, and identify the combination of materials and workers to increase production. *On Demand Until May 6, 2022*

Technology Forum Series: Strategies to Prevent Drug Shortages and Resolve Capacity Challenges

***Session 1: Thursday, April 22, 2021, 10am EDT, Session 2: Thursday, April 22, 2021, 11am EDT, Session 3: Thursday, April 22, 2021, 1pm EDT*** A drug’s journey from development to manufacturing to patients is paved with roadblocks and potholes; many threats can derail bio/pharmaceutical processes. Potential solutions to such pitfalls have been discussed for years; however, few manufacturers have embraced technology and process advances to proactively ensure drug supply chain continuity.